A Tulsa-based gas station chain is using its knowledge of how to serve customers and locate shops in easy-to-find spots to enter the urgent care industry, which has doubled in size over the past decade. Experts question how the explosion of convenient clinics will affect care costs and wait times.
In the early 1970s, public health workers buoyed by the motto “zero pox!” worked across India to achieve 100% vaccination against smallpox. This episode is about what happened when these zealous young people encountered hesitation.
Kaiser Permanente, the California-based health care giant, is looking to dramatically expand its national presence. It’s committed $5 billion to a new unit called Risant Health and has agreed to acquire Pennsylvania-based Geisinger, but skeptics wonder how it will export its unique model to other states.
As hospitals are criticized for skimping on financial assistance, Santa Clara County has agreed to notify 43,000 former patients of possible billing reductions as part of a settlement. Some patients had sued, alleging the county’s hospital system sent them to collections for bills they shouldn’t have received.
A Biden administration proposal would help standardize the data on prices that hospitals provide to patients, increase its usefulness to consumers, and boost enforcement. Previous rules gave hospitals too many loopholes.
The day-to-day struggles that parents of kids with mental health conditions must navigate have led to their own crisis: The stress can take a physical toll that disrupts parents’ ability to provide care, say psychologists, researchers, and advocates for families.
After decades of unchecked mergers, health care is the land of giants, with huge medical systems monopolizing care in many cities, states, and even whole regions of the country. This decreases patient choice, impedes innovation, erodes quality of care, and raises prices. And federal regulators have been slow to act.
Clinics serving Alzheimer’s patients are working out the details of who will get treated with the new drug Leqembi. It won’t be for everyone with memory-loss symptoms.
The first of a new wave of cancer-detection blood tests likely saved Gilbert Milam Jr.’s life. But many cancer researchers, wary of overtesting, argue it’s premature to prescribe the Galleri test widely.
Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.
